Osteoarthritis study: Physical Therapy
Official title Intra-articular Corticosteroid With Hyaluronic Acid Plus Physiotherapy for Hip Pathologies (NON-OP HIP)
ClinicalTrials.gov ID: NCT06653985
What this study is testing
What is Hyaluronic and corticosteroid injection?
An investigational injection being studied for relief of hip osteoarthritis pain and function. is designed to combine the quick anti‑inflammatory effects of corticosteroid with the longer‑lasting joint lubrication of hyaluronic acid.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study wants to see whether adding physiotherapy to a combined steroid and hyaluronic acid hip injection improves pain and function compared with the injection alone.
- Who it's for
- Adults who have hip pain from osteoarthritis, femoroacetabular impingement, or a labral tear and are not yet ready for surgery.
- What's involved
- Participants receive a single hip injection of steroid and hyaluronic acid and then either start a physiotherapy program or receive no physiotherapy. They will have follow‑up visits and tests to track pain and hip function.
- Time commitment
- The study lasts several months, with scheduled visits for the injection, physiotherapy sessions (if assigned), and follow‑up assessments to monitor progress.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 60
You may be able to join if
- Patients aged 40-60 years old.
- Patients with mild hip arthritis (Kellgren-Lawrence grade 2 or lower) with or without a labral tear and/or femoroacetabular impingement and/or mild...
- Patients who demonstrate more than 50% reduction in hip pain following a diagnostic injection (ultrasound guided intra-articular anaesthetic only).
- Able to subsidize private physiotherapy services.
- Able to provide informed consent.
You likely can't join if
- Active infection
- Osteonecrosis of the hip, moderate to severe arthritis (Kellgren-Lawrence grade 3 or higher), or moderate-to-severe hip dysplasia
- Previous hip fracture, pelvic fracture, or lower limb fracture,
- Previous surgery to the pelvis, hip or lower limb
- Hypermobility disorder or connective tissue disease (e.g. Ehler's-Danlos syndrome, Marfan's syndrome etc.)
- Patients with chronic low back pain and/or sciatica
See the full eligibility criteria
- Patients aged 40-60 years old.
- Patients with mild hip arthritis (Kellgren-Lawrence grade 2 or lower) with or without a labral tear and/or femoroacetabular impingement and/or mild hip dysplasia.
- Patients who demonstrate more than 50% reduction in hip pain following a diagnostic injection (ultrasound guided intra-articular anaesthetic only).
- Able to subsidize private physiotherapy services.
- Able to provide informed consent.
- Active infection
- Osteonecrosis of the hip, moderate to severe arthritis (Kellgren-Lawrence grade 3 or higher), or moderate-to-severe hip dysplasia
- Previous hip fracture, pelvic fracture, or lower limb fracture,
- Previous surgery to the pelvis, hip or lower limb
- Hypermobility disorder or connective tissue disease (e.g. Ehler's-Danlos syndrome, Marfan's syndrome etc.)
- Patients with chronic low back pain and/or sciatica
- Patients who received an intra-articular steroid hip injection within 3 months
- Patients who have previously received a hyaluronic acid injection
- Injuries sustained in a motor vehicle collision.
- Injuries sustained in the workplace and have a worker's compensation claim.
- Injuries resulting in a medico-legal dispute.
- Patients who are pregnant of planning to become pregnant
- Currently enrolled in a study that does not permit co-enrollment
- Unable to obtain informed consent
- Unable to comply with the study protocol
- Contraindication to corticosteroid or hyaluronic acid injection
- Prior enrollment in the study.
The study team makes the final eligibility decision.
Where it is enrolling
- Hamilton, Ontario, Canada
Compensation & support
This study's listing mentions compensation or reimbursement.
No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hamilton, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.